Last updated: Nov 6, 2026, 4:42 PM UTC
Latest Officer Sales $25K+
Browse recent insider trading sales of $25,000 or more by company officers, including CEOs, CFOs, and vice presidents. In the most recent SEC Form 4 filing, Ryerson Holding Corp's ceo reported selling 21,968 RYZ shares at $31.22 each. The table shows each officer's role, sale value, and change in holdings. Use the color tags and SEC links to check for stock-plan or prearranged-trade details.
These filings are deferred by 6 hours & limited to 50 category trades. Sign up for real time updates and 20 years of data.
View Latest Alerts
Notable Patterns
Latest Cluster Buys
Latest Penny Stock Buys
Biggest Buys This Week
Biggest Buys This Month
Latest Insider Trading - All Filings
Latest Insider Purchases
Latest Insider Purchases $25K+
Latest Insider Purchases $100K+
Latest Officer Purchases $25K+
Latest Officer Purchases $100K+
Latest CEO/CFO Purchases $25K+
Latest CEO/CFO Purchases $100K+
Latest Insider Sales
Latest Insider Sales $25K+
Latest Insider Sales $100K+
Latest Officer Sales $25K+
Latest Officer Sales $100K+
Latest CEO/CFO Sales $25K+
Latest CEO/CFO Sales $100K+
Loading alerts
50 trades of 29436 total
| File Date | Date of Earliest Transaction | Date of Latest Transaction | Ticker Symbol | Company | Insider Name | Insider Title | Buy/Sell | Transaction Count | Shares Transacted | Price | Total Transaction Value | Total Shares Owned After Transaction | Position Size Change | SEC Link |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. 2026-11-05 | 2026-11-04 | 2026-11-04 | RYZ | Ryerson Holding Corp | Lehner Edward J. | CEO | Sell | 1 | 21,968 | $31.22 | $685,840.96 | 623,596.48 | 3.40% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-11-05 | 2026-11-05 | 2026-11-05 | ADMA | Adma Biologics, Inc. | Grossman Adam S | President and CEO | Sell | 1 | 105,000 | $12.00 | $1,260,000.00 | 2,112,777 | 4.73% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-11-05 | 2026-11-05 | 2026-11-05 | ADMA | Adma Biologics, Inc. | Grossman Adam S | President and CEO | Sell | 1 | 42,000 | $12.00 | $504,000.00 | 2,070,777 | 1.99% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-11-05 | 2026-11-04 | 2026-11-05 | TTAN | Servicetitan, Inc. | Mahdessian Ara | Chief Executive Officer | Sell | 11 | 105,000 | $85.97 | $9,027,037.20 | 0 | 100.00% | View filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. 2026-11-05 | 2026-11-04 | 2026-11-04 | NFLX | Netflix Inc | Sarandos Theodore A | Co-CEO | Sell | 1 | 27,312 | $66.20 | $1,808,048.94 | 178,954 | 13.24% | View filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. 2026-11-05 | 2026-11-04 | 2026-11-04 | NFLX | Netflix Inc | Neumann Spencer Adam | Chief Financial Officer | Sell | 1 | 9,253 | $66.15 | $612,109.08 | 73,787 | 11.14% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-11-05 | 2026-11-03 | 2026-11-03 | GRAB | Grab Holdings Ltd | Ong Chin Yin | Chief Org Capability Officer | Sell | 1 | 38,000 | $3.21 | $121,980.00 | 3,556,611 | 1.06% | View filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. 2026-11-05 | 2026-11-03 | 2026-11-03 | GATX | Gatx Corp | Lyons Robert C | President and CEO | Sell | 2 | 12,265 | $186.00 | $2,281,307.97 | 56,510 | 17.83% | View filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. 2026-11-05 | 2026-11-04 | 2026-11-04 | VTMX | Vesta Real Estate Corporation, S.A.B. De C.V. | Berho Carranza Diego | Chief Portfolio Officer | Sell | 2 | 45,000 | $3.73 | $167,850.00 | 1,636,661 | 2.68% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-11-05 | 2026-11-03 | 2026-11-03 | DGX | Quest Diagnostics Inc | Doherty Catherine T. | Executive Vice President | Sell | 7 | 22,105 | $248.02 | $5,482,442.39 | 71,949 | 23.50% | View filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. 2026-11-05 | 2026-11-03 | 2026-11-03 | SCHW | Schwab Charles Corp | Schwab Charles R. | Co-Chairman | Sell | 1 | 11,675 | $89.21 | $1,041,583.96 | 53,334,616 | 0.02% | View filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. 2026-11-05 | 2026-11-04 | 2026-11-04 | VTMX | Vesta Real Estate Corporation, S.A.B. De C.V. | Sottil Achutegui Juan Felipe | CHIEF FINANCIAL OFFICER | Sell | 1 | 330,714 | $3.71 | $1,226,948.94 | 609,567 | 35.17% | View filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. 2026-11-05 | 2026-11-05 | 2026-11-05 | EXR | Extra Space Storage Inc. | Sondhi Samrat | Executive VP and CDO | Sell | 1 | 5,000 | $161.84 | $809,200.00 | 104,244 | 4.58% | View filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. 2026-11-05 | 2026-11-04 | 2026-11-04 | VTMX | Vesta Real Estate Corporation, S.A.B. De C.V. | Bettinger Davo Maria Fernanda | INVESTOR RELATIONS OFFICER | Sell | 1 | 29,000 | $3.70 | $107,300.00 | 64,423 | 31.04% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-11-05 | 2026-11-03 | 2026-11-03 | JAZZ | Jazz Pharmaceuticals Plc | Gala Renee D | President & CEO | Sell | 1 | 1,000 | $225.37 | $225,370.00 | 140,394 | 0.71% | View filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. 2026-11-05 | 2026-11-04 | 2026-11-04 | UDR | Udr, Inc. | Lacy Michael D | SVP-COO | Sell | 1 | 10,000 | $36.48 | $364,800.00 | 783 | 92.74% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-11-05 | 2026-11-03 | 2026-11-03 | AAPL | Apple Inc. | Newstead Jennifer | SVP, GC and Government Affairs | Sell | 1 | 2,399 | $325.75 | $781,474.25 | 29,997 | 7.41% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-11-05 | 2026-11-03 | 2026-11-03 | RSI | Rush Street Interactive, Inc. | Sauers Kyle | Chief Financial Officer | Sell | 1 | 23,000 | $12.00 | $276,000.00 | 555,417 | 3.98% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-11-05 | 2026-11-03 | 2026-11-03 | ROIV | Roivant Sciences Ltd. | Venker Eric | President & Immunovant CEO | Sell | 1 | 200,000 | $36.31 | $7,262,000.00 | 999,154 | 16.68% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-11-05 | 2026-11-04 | 2026-11-04 | DIS | Walt Disney Co | Woodford Brent | EVP, Control, Fin Plan & Tax | Sell | 1 | 3,618 | $117.00 | $423,306.00 | 62,995 | 5.43% | View filing |
| Explained M/S: sale activity tied to share conversions or derivative-related share movements. 2026-11-05 | 2026-11-03 | 2026-11-03 | SHW | Sherwin Williams Co | Young Bryan J | SVP - Corp Strategy & Devel | Sell | 1 | 1,314 | $345.71 | $454,262.94 | 10,045 | 11.57% | View filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. 2026-11-05 | 2026-11-03 | 2026-11-03 | SHW | Sherwin Williams Co | Jaye James R | SVP - IR & Corp. Comm | Sell | 1 | 2,301 | $345.56 | $795,133.56 | 6,936.31 | 24.91% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-11-05 | 2026-11-03 | 2026-11-03 | PRCH | Porch Group, Inc. | Ehrlichman Matt | CEO, CHAIRMAN AND FOUNDER | Sell | 1 | 10,000 | $21.51 | $215,124.00 | 15,891,745 | 0.06% | View filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. 2026-11-05 | 2026-11-05 | 2026-11-05 | OBT | Orange County Bancorp, Inc. /De/ | Ruhl Joseph A | Reg Pres, Westchester County | Sell | 1 | 1,923 | $40.27 | $77,439.21 | 32,859 | 5.53% | View filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. 2026-11-05 | 2026-11-03 | 2026-11-04 | H | Hyatt Hotels Corp | Hoplamazian Mark Samuel | Chairman, President and Chief Executive Officer | Sell | 7 | 85,000 | $188.23 | $15,999,452.68 | 271,089 | 23.87% | View filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. 2026-11-05 | 2026-11-03 | 2026-11-03 | H | Hyatt Hotels Corp | Egan Margaret C. | Executive Vice President, General Counsel and Secretary | Sell | 1 | 1,100 | $186.78 | $205,458.00 | 33,404 | 3.19% | View filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting 2026-11-05 | 2026-11-03 | 2026-11-03 | KMTS | Kestra Medical Technologies, Ltd. | Moran Timothy P. | Chief Business Officer | Sell | 1 | 3,192 | $29.56 | $94,352.01 | 63,153 | 4.81% | View filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. 2026-11-05 | 2026-11-04 | 2026-11-04 | H | Hyatt Hotels Corp | Vondrasek Mark R | Executive Vice President, Chief Commercial Officer | Sell | 1 | 5,072 | $189.77 | $962,513.44 | 8,988 | 36.07% | View filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. 2026-11-05 | 2026-11-03 | 2026-11-03 | VLTO | Veralto Corp | Bystrom Mattias | SVP, PQI | Sell | 9 | 9,069 | $116.30 | $1,054,679.47 | 35,536 | 20.33% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-11-05 | 2026-11-03 | 2026-11-04 | ARHS | Arhaus, Inc. | Reed John P | CEO and Chairman | Sell | 2 | 147,431 | $12.63 | $1,862,298.79 | 115,799 | 56.01% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-11-05 | 2026-11-03 | 2026-11-04 | CNXN | Pc Connection Inc | Gallup Patricia | Chairman & Chief Admin Officer | Sell | 5 | 14,284 | $88.04 | $1,257,569.26 | 6,884,907 | 0.21% | View filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. 2026-11-05 | 2026-11-04 | 2026-11-04 | FFIV | F5, Inc. | Montoya Michael F | Chief Technology Ops Officer | Sell | 6 | 1,257 | $329.46 | $414,134.00 | 1,349 | 48.23% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-11-05 | 2026-11-04 | 2026-11-04 | UTHR | United Therapeutics Corp | Rothblatt Martine A | Chairperson & CEO | Sell | 4 | 1,723 | $611.06 | $1,052,853.99 | 324,443 | 0.53% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-11-05 | 2026-11-04 | 2026-11-04 | UTHR | United Therapeutics Corp | Rothblatt Martine A | Chairperson & CEO | Sell | 24 | 7,777 | $599.64 | $4,663,395.87 | 326,166 | 2.33% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-11-05 | 2026-11-04 | 2026-11-04 | FFIV | F5, Inc. | Fountain Thomas Dean | EVP Global Services & Strategy | Sell | 1 | 9,387 | $329.74 | $3,095,268.44 | 8,060 | 53.80% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-11-05 | 2026-11-03 | 2026-11-03 | FFIV | F5, Inc. | Anand Kunal | Chief Technology Officer | Sell | 1 | 1,989 | $324.06 | $644,555.34 | 14,578 | 12.01% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-11-05 | 2026-11-05 | 2026-11-05 | UTHR | United Therapeutics Corp | Mahon Paul A | EVP & GENERAL COUNSEL | Sell | 9 | 8,300 | $598.67 | $4,968,932.80 | 45,172 | 15.52% | View filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. 2026-11-05 | 2026-11-03 | 2026-11-03 | FFIV | F5, Inc. | Whalen Chad Michael | EVP, Worldwide Sales | Sell | 6 | 6,790 | $329.65 | $2,238,290.48 | 25,467 | 21.05% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-11-05 | 2026-11-03 | 2026-11-03 | FFIV | F5, Inc. | Whalen Chad Michael | EVP, Worldwide Sales | Sell | 2 | 160 | $325.83 | $52,132.80 | 31,473 | 0.51% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-11-05 | 2026-11-03 | 2026-11-03 | FFIV | F5, Inc. | Maddison John Anthony | Chief Product Mkting Officer | Sell | 1 | 619 | $324.06 | $200,593.14 | 1,566 | 28.33% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-11-05 | 2026-11-03 | 2026-11-03 | FFIV | F5, Inc. | Werner Edward Cooper | Chief Financial Officer | Sell | 1 | 599 | $324.06 | $194,111.94 | 2,851 | 17.36% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-11-05 | 2026-11-03 | 2026-11-03 | FFIV | F5, Inc. | Okeke Angelique M | EVP, General Counsel | Sell | 1 | 1,007 | $324.06 | $326,328.42 | 2,862 | 26.03% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-11-05 | 2026-11-04 | 2026-11-04 | CVCO | Cavco Industries, Inc. | Schuknecht Seth G | EVP, General Counsel | Sell | 1 | 542 | $685.00 | $371,270.00 | 1,323 | 29.06% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-11-05 | 2026-11-04 | 2026-11-04 | CHWY | Chewy, Inc. | Billings William G. | Chief Accounting Officer | Sell | 1 | 4,815 | $23.00 | $110,745.00 | 36,595 | 11.63% | View filing |
| Explained M/S: sale activity tied to share conversions or derivative-related share movements. 2026-11-05 | 2026-11-05 | 2026-11-05 | TSBK | Timberland Bancorp Inc | Fischer Jonathan Arthur | President/COO | Sell | 1 | 2,000 | $47.76 | $95,520.00 | 8,095 | 19.81% | View filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. 2026-11-05 | 2026-11-04 | 2026-11-04 | IDXX | Idexx Laboratories Inc /De | Underberg Sharon E. | EVP, GC & Corporate Secretary | Sell | 3 | 8,906 | $688.59 | $6,132,604.99 | 7,168.65 | 55.40% | View filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. 2026-11-05 | 2026-11-04 | 2026-11-04 | IDXX | Idexx Laboratories Inc /De | Mazelsky Jonathan Jay | Executive Chair of the Board | Sell | 13 | 25,140 | $703.19 | $17,678,194.61 | 83,803.30 | 23.08% | View filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. 2026-11-05 | 2026-11-04 | 2026-11-04 | IDXX | Idexx Laboratories Inc /De | Lane Michael | Executive Vice President | Sell | 3 | 3,978.94 | $688.64 | $2,740,069.40 | 4,076 | 49.40% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-11-05 | 2026-11-03 | 2026-11-04 | DFIN | Donnelley Financial Solutions, Inc. | Leib Daniel | Chief Executive Officer | Sell | 5 | 15,000 | $68.49 | $1,027,286.94 | 596,315 | 2.45% | View filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. 2026-11-05 | 2026-11-03 | 2026-11-03 | TW | Tradeweb Markets Inc. | Bruni Enrico | MD, Co-Head of Global Markets | Sell | 2 | 18,500 | $126.26 | $2,335,815.86 | 108,234 | 14.60% | View filing |
Loading alerts